2024 RT Amination Banner.gif

China Daily

News> Nation> Content
Sunday, June 21, 2020, 17:44
COVID-19 vaccine reaches phase-2 trials in China
By Xinhua
Sunday, June 21, 2020, 17:44 By Xinhua

A staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd, in Beijing, capital of China, March 16, 2020. (ZHANG YUWEI / XINHUA)

BEIJING – An inactivated COVID-19 vaccine candidate developed by the Institute of Medical Biology under the Chinese Academy of Medical Sciences has entered phase-2 clinical trials in China, the Science and Technology Daily reported Saturday.

ALSO READ: Official: China to make COVID-19 vaccine global public good

The phase-2 trials, which further evaluate the immunogenicity and safety of the vaccine in humans, are being conducted in the southwestern province of Yunnan.

READ MORE: Vaccine R&D not competition, says Foreign Ministry

So far, five COVID-19 vaccine candidates have been approved for clinical trials in China, accounting for 40 percent of the total vaccines in clinical trials worldwide, according to the Ministry of Science and Technology.

Share this story

CHINA DAILY
HONG KONG NEWS
OPEN
Please click in the upper right corner to open it in your browser !